GL1X · GenesisL1 explorer

Research workbench

Crystal structure of GD2 bound pltb

Analyse Crystal structure of GD2 bound pltb in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4RHS
Type
protein
Length
571 residues
Chains
5
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Putative pertussis-like toxin subunit
UniProt
Q8Z6A3
Ligands
SIA, GAL
Pockets
1 · best druggability 0.71

Structure

x-ray diffraction · 2 distinct chains · 20% helix, 42% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, C, D, EPutative pertussis-like toxin subunitprotein11420% helix, 42% strandQ8Z6A3
BPutative pertussis-like toxin subunitprotein11520% helix, 42% strandQ8Z6A3

Ligands and binding sites

  • SIA · N-acetyl-alpha-neuraminic acid · sugar · 4 copies · chains C, E
  • GAL · beta-D-galactopyranose · sugar · 2 copies
  • ACT · Acetate ion · additive · 2 copies · chains B, E

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18520.710.7636empty

Interfaces

5 interfaces between chains.

  • C–D · 1099 Ų buried · 24 hydrogen bonds · protein-protein
  • D–E · 1077 Ų buried · 23 hydrogen bonds · protein-protein
  • A–C · 1072 Ų buried · 26 hydrogen bonds · protein-protein
  • A–B · 1065 Ų buried · 24 hydrogen bonds · protein-protein
  • B–E · 1058 Ų buried · 23 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 10 disulfide (disulfide).

Compared structures

  • 4RHS · Crystal structure of GD2 bound PltB · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.